Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of Lexaria Bioscience Corp. from 31 Oct 2013 to 30 Nov 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
- Summary
-
Lexaria Bioscience Corp. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD history and change rate from 31 Oct 2013 to 30 Nov 2025.
- Lexaria Bioscience Corp. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending 30 Nov 2025 was $4,523,454, a 52% decline year-over-year.
- Source SEC data
- View on sec.gov
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Change (%)
Lexaria Bioscience Corp. Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $4,523,454 | -$4,870,602 | -52% | 30 Nov 2025 | 10-Q | 13 Jan 2026 | 2026 | Q1 |
| Q3 2025 | $2,602,755 | -$5,056,296 | -66% | 31 Aug 2025 | 10-Q | 13 Jan 2026 | 2026 | Q1 |
| Q2 2025 | $5,166,521 | -$4,580,541 | -47% | 31 May 2025 | 10-Q | 14 Jul 2025 | 2025 | Q3 |
| Q1 2025 | $6,760,768 | +$612,928 | +10% | 28 Feb 2025 | 10-Q | 14 Jul 2025 | 2025 | Q3 |
| Q4 2024 | $9,394,056 | +$6,021,322 | +179% | 30 Nov 2024 | 10-Q | 13 Jan 2026 | 2026 | Q1 |
| Q3 2024 | $7,659,051 | +$4,978,973 | +186% | 31 Aug 2024 | 10-Q | 13 Jan 2026 | 2026 | Q1 |
| Q2 2024 | $9,747,062 | +$5,705,916 | +141% | 31 May 2024 | 10-Q | 14 Jul 2025 | 2025 | Q3 |
| Q1 2024 | $6,147,840 | +$1,515,992 | +33% | 29 Feb 2024 | 10-Q | 14 Jul 2025 | 2025 | Q3 |
| Q4 2023 | $3,372,734 | -$2,559,226 | -43% | 30 Nov 2023 | 10-Q | 14 Jul 2025 | 2025 | Q3 |
| Q3 2023 | $2,680,078 | -$4,952,412 | -65% | 31 Aug 2023 | 10-K | 28 Nov 2025 | 2025 | FY |
| Q2 2023 | $4,041,146 | -$4,871,632 | -55% | 31 May 2023 | 10-Q | 12 Jul 2024 | 2024 | Q3 |
| Q1 2023 | $4,631,848 | -$6,588,094 | -59% | 28 Feb 2023 | 10-Q | 12 Jul 2024 | 2024 | Q3 |
| Q4 2022 | $5,931,960 | -$5,536,654 | -48% | 30 Nov 2022 | 10-Q | 12 Jul 2024 | 2024 | Q3 |
| Q3 2022 | $7,632,490 | -$3,836,124 | -33% | 31 Aug 2022 | 10-K | 26 Nov 2024 | 2024 | FY |
| Q2 2022 | $8,912,778 | -$1,353,396 | -13% | 31 May 2022 | 10-Q | 14 Jul 2023 | 2023 | Q3 |
| Q1 2022 | $11,219,942 | -$482,923 | -4.1% | 28 Feb 2022 | 10-Q | 14 Jul 2023 | 2023 | Q3 |
| Q4 2021 | $11,468,614 | +$9,647,590 | +530% | 30 Nov 2021 | 10-Q | 14 Jul 2023 | 2023 | Q3 |
| Q3 2021 | $11,468,614 | +$8,986,356 | +362% | 30 Sep 2021 | 10-Q | 14 Jul 2022 | 2022 | Q3 |
| Q2 2021 | $10,266,174 | +$7,065,641 | +221% | 31 May 2021 | 10-Q | 14 Jul 2022 | 2022 | Q3 |
| Q1 2021 | $11,702,865 | +$9,779,929 | +509% | 28 Feb 2021 | 10-Q | 14 Jul 2022 | 2022 | Q3 |
| Q4 2020 | $1,821,024 | -$794,111 | -30% | 30 Nov 2020 | 10-Q | 14 Jul 2022 | 2022 | Q3 |
| Q3 2020 | $2,482,258 | -$8,454 | -0.34% | 31 Aug 2020 | 10-K | 28 Nov 2022 | 2022 | FY |
| Q2 2020 | $3,200,533 | -$124,272 | -3.7% | 31 May 2020 | 10-Q | 14 Apr 2021 | 2021 | Q2 |
| Q1 2020 | $1,922,936 | -$1,850,528 | -49% | 29 Feb 2020 | 10-Q | 14 Apr 2021 | 2021 | Q2 |
| Q4 2019 | $2,615,135 | -$799,141 | -23% | 30 Nov 2019 | 10-Q | 14 Apr 2021 | 2021 | Q2 |
| Q3 2019 | $2,490,712 | +$102,526 | +4.3% | 31 Aug 2019 | 10-Q | 14 Apr 2021 | 2021 | Q2 |
| Q2 2019 | $3,324,805 | +$687,369 | +26% | 31 May 2019 | 10-Q | 29 Jun 2020 | 2020 | Q3 |
| Q1 2019 | $3,773,464 | +$1,001,265 | +36% | 28 Feb 2019 | 10-Q | 29 Jun 2020 | 2020 | Q3 |
| Q4 2018 | $3,414,276 | +$1,012,756 | +42% | 30 Nov 2018 | 10-Q | 29 Jun 2020 | 2020 | Q3 |
| Q3 2018 | $2,388,186 | -$379,645 | -14% | 31 Aug 2018 | 10-K | 15 Oct 2020 | 2020 | FY |
| Q2 2018 | $2,637,436 | -$421,897 | -14% | 31 May 2018 | 10-Q | 13 Jul 2018 | 2018 | Q3 |
| Q1 2018 | $2,772,199 | +$2,281,627 | +465% | 28 Feb 2018 | 10-Q | 12 Apr 2018 | 2018 | Q2 |
| Q4 2017 | $2,401,520 | +$1,778,178 | +285% | 30 Nov 2017 | 10-Q | 12 Jan 2018 | 2018 | Q1 |
| Q3 2017 | $2,767,831 | +$2,680,074 | +3054% | 31 Aug 2017 | 10-K | 14 Nov 2019 | 2019 | FY |
| Q2 2017 | $3,059,333 | +$3,104,618 | 31 May 2017 | 10-Q | 14 Jul 2017 | 2017 | Q3 | |
| Q1 2017 | $490,572 | +$385,424 | +367% | 28 Feb 2017 | 10-Q | 14 Apr 2017 | 2017 | Q2 |
| Q4 2016 | $623,342 | +$304,614 | +96% | 30 Nov 2016 | 10-Q | 13 Jan 2017 | 2017 | Q1 |
| Q3 2016 | $87,757 | -$568,840 | -87% | 31 Aug 2016 | 10-K | 14 Nov 2018 | 2018 | FY |
| Q2 2016 | $45,285 | -$1,181,532 | -104% | 31 May 2016 | 10-Q | 13 Jul 2016 | 2016 | Q3 |
| Q1 2016 | $105,148 | -$1,067,206 | -91% | 29 Feb 2016 | 10-Q | 13 Apr 2016 | 2016 | Q2 |
| Q4 2015 | $318,728 | -$1,143,035 | -78% | 30 Nov 2015 | 10-Q | 08 Jan 2016 | 2016 | Q1 |
| Q3 2015 | $656,597 | -$1,060,501 | -62% | 31 Aug 2015 | 10-K | 14 Nov 2018 | 2018 | FY |
| Q2 2015 | $1,136,247 | 31 May 2015 | 10-Q | 14 Jul 2015 | 2015 | Q3 | ||
| Q1 2015 | $1,172,354 | 28 Feb 2015 | 10-Q | 14 Apr 2015 | 2015 | Q2 | ||
| Q4 2014 | $1,461,763 | 30 Nov 2014 | 10-Q | 14 Jan 2015 | 2015 | Q1 | ||
| Q3 2014 | $1,717,098 | -$381,805 | -18% | 31 Aug 2014 | 10-K | 29 Nov 2016 | 2016 | FY |
| Q3 2013 | $2,098,903 | 31 Oct 2013 | 10-K | 27 Nov 2015 | 2015 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.